Rare Disease Drug Development Increases but Challenges Remain

In a recent study published by Tufts University, researchers found that rare disease drug development is now one of the fastest growing areas in drug R&D, with nearly one-third of all products in the global R&D pipeline targeting treatments for rare disease indications.
Yet while innovative biopharmaceutical companies have increased R&D investment in rare disease drug development in recent years, challenges remain. For example, the report indicates that:
Clinical through approval pha